Connect your AI

CorMedix CRMD Change in Other Assets

Change in Other Assets at other companies

PfizerPFE

-$322.25M+61.9%

Merit Medical SystemsMMSI

-$1.89M+7.6%

ITG

Integer HoldingsITGR

$2.84M+143%

IAR

Integra LifeSciencesIART

$21.88M+24.6%

Emergent BiosolutionsEBS

$500K+105%

ICU MedicalICUI

$14.35M+69.5%

Other financials

Income statement

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CorMedix's change in other assets?: CorMedix (CRMD) reported change in other assets of $2.26M in Q1 2026.
How has CorMedix's change in other assets changed year-over-year?: CorMedix's change in other assets decreased by 0.4% year-over-year, from $2.27M to $2.26M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.